Home › Funds › Stonepine Capital Management, LLC › NMRA

Stonepine Capital Management, LLC position in NMRA

NEUMORA THERAPEUTICS INC. · Health Care

Stonepine Capital Management, LLC reported holding 787,269 shares of NMRA (NEUMORA THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$469K, representing 0.36% of its reported portfolio and ranking #47 among its reported holdings. Stonepine Capital Management, LLC has disclosed NMRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)787.27K sh
Reported value held$469.37K
Portfolio Weight0.36%
First reportedQ1 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's NMRA position evolved

Stonepine Capital Management, LLC first disclosed a stake in NMRA in Q1 2026 at 100,000 shares (US$195K). The position peaked in Q2 2026 at 500,000 shares, worth US$1.2M. Across 3 filings, Stonepine Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 787,269 shares valued at US$469K — an increase of 287,269 shares quarter over quarter.. Notable position changes include a 400% increase in Q2 2026 (shares fell 65% over the following quarter), a 57% increase in Q3 2026 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 100.00K $195.00K New
Q2 2026 500.00K $1.25M Add
Q3 2026 787.27K $469.37K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NMRA and 13F data

NMRA (NEUMORA THERAPEUTICS INC.) is a Health Care company. 18 other funds we track also report a position in NMRA — the largest reported positions include SOFTBANK GROUP CORP. (US$10.4M), ICONIQ Capital, LLC (US$4.4M), Boxer Capital Management, LLC (US$3.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NMRA

All NMRA fund holders →

FAQ

How long has Stonepine Capital Management, LLC held NMRA?

Stonepine Capital Management, LLC has disclosed NMRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Stonepine Capital Management, LLC's current position in NMRA?

As of Q3 2026, Stonepine Capital Management, LLC holds 787.27K shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $469.37K, representing 0.36% of its reported portfolio and ranking #47.

Has Stonepine Capital Management, LLC been buying or selling NMRA?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC increased its position in NMRA. The position peaked in Q2 2026 at 500.00K shares.

Which other funds hold NMRA?

Other major institutional holders of NMRA include SOFTBANK GROUP CORP., ICONIQ Capital, LLC, Boxer Capital Management, LLC, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.